Published in Ther Adv Neurol Disord on July 01, 2013
Diffuse and focal corticospinal tract disease and its impact on patient disability in multiple sclerosis. J Neuroimaging (2014) 0.81
Precision Medicine in Multiple Sclerosis: Future of PET Imaging of Inflammation and Reactive Astrocytes. Front Mol Neurosci (2016) 0.80
Quantitative Evaluation of Intensity Inhomogeneity Correction Methods for Structural MR Brain Images. Neuroinformatics (2016) 0.78
Intensity Inhomogeneity Correction of Structural MR Images: A Data-Driven Approach to Define Input Algorithm Parameters. Front Neuroinform (2016) 0.75
Differential diagnosis of neuromyelitis optica spectrum disorders. Ther Adv Neurol Disord (2017) 0.75
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol (2011) 25.66
Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol (2001) 24.36
Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol (2005) 24.22
Revised diagnostic criteria for neuromyelitis optica. Neurology (2006) 17.57
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet (2004) 13.18
Multiple sclerosis. N Engl J Med (2000) 12.69
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med (2005) 10.39
The clinical course of neuromyelitis optica (Devic's syndrome). Neurology (1999) 8.03
Brain abnormalities in neuromyelitis optica. Arch Neurol (2006) 4.28
Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology (2007) 4.25
Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology (2007) 4.23
Inflammatory cortical demyelination in early multiple sclerosis. N Engl J Med (2011) 4.02
Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology (2002) 4.01
Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up. Arch Neurol (2008) 3.92
Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain (1997) 3.87
Acute fulminant demyelinating disease: a descriptive study of 60 patients. Arch Neurol (2007) 3.81
Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays. Neurology (2012) 3.79
A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med (2002) 3.74
Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome. Neurology (2008) 3.68
IFNβ-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum. Neurology (2010) 3.34
Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol (2006) 3.26
Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis. Brain (2008) 3.05
Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children. Brain (2000) 2.96
Acute disseminated encephalomyelitis: a long-term follow-up study of 84 pediatric patients. Neurology (2002) 2.90
The clinico-radiological paradox in multiple sclerosis revisited. Curr Opin Neurol (2002) 2.85
Acute disseminated encephalomyelitis. Neurology (2007) 2.84
Gray matter involvement in multiple sclerosis. Neurology (2007) 2.75
Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. Brain (2008) 2.67
MRI as an outcome in multiple sclerosis clinical trials. Neurology (2008) 2.62
Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol (1999) 2.61
Diffusion tensor imaging of lesions and normal-appearing white matter in multiple sclerosis. Neurology (1999) 2.54
Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. Radiology (2005) 2.47
Progressive cerebral atrophy in MS: a serial study using registered, volumetric MRI. Neurology (2000) 2.47
The measurement and clinical relevance of brain atrophy in multiple sclerosis. Lancet Neurol (2006) 2.47
MRI and the diagnosis of multiple sclerosis: expanding the concept of "no better explanation". Lancet Neurol (2006) 2.44
Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. Radiology (1992) 2.41
Establishing a baseline phase behavior in magnetic resonance imaging to determine normal vs. abnormal iron content in the brain. J Magn Reson Imaging (2007) 2.34
Disability in optic neuritis correlates with diffusion tensor-derived directional diffusivities. Neurology (2008) 2.33
Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders. Neurology (2007) 2.32
Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain (2002) 2.30
Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis. Brain (1988) 2.29
Major differences in the dynamics of primary and secondary progressive multiple sclerosis. Ann Neurol (1991) 2.25
Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis. Neurology (1998) 2.17
Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI. Neurology (2011) 2.17
Postmortem verification of MS cortical lesion detection with 3D DIR. Neurology (2012) 2.16
A comparison of MRI criteria for diagnosing pediatric ADEM and MS. Neurology (2010) 2.02
Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome. Neurology (2011) 2.02
The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up. Brain (1998) 1.99
Role of MRI in the differentiation of ADEM from MS in children. Neurology (2008) 1.94
Use of serial proton magnetic resonance spectroscopy to differentiate low grade glioma from tumefactive plaque in a patient with multiple sclerosis. Br J Radiol (2003) 1.92
Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study. Lancet Neurol (2011) 1.92
MRI criteria for MS in patients with clinically isolated syndromes. Neurology (2010) 1.90
Open-ring imaging sign: highly specific for atypical brain demyelination. Neurology (2000) 1.80
MRI in the diagnosis of pediatric multiple sclerosis. Neurology (2008) 1.73
Progressive cerebral atrophy in multiple sclerosis. A serial MRI study. Brain (1996) 1.69
Gray matter T2 hypointensity is related to plaques and atrophy in the brains of multiple sclerosis patients. J Neurol Sci (2001) 1.64
Correlating MRI and clinical disease activity in multiple sclerosis: relevance of hypointense lesions on short-TR/short-TE (T1-weighted) spin-echo images. Neurology (1995) 1.63
Diagnosis of neuromyelitis spectrum disorders: comparative sensitivities and specificities of immunohistochemical and immunoprecipitation assays. Arch Neurol (2009) 1.61
Investigation of MS normal-appearing brain using diffusion tensor MRI with clinical correlations. Neurology (2001) 1.58
Quantitative MRI in patients with clinically isolated syndromes suggestive of demyelination. Neurology (1999) 1.58
Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance. Arch Neurol (2003) 1.55
Does interferon beta treatment exacerbate neuromyelitis optica spectrum disorder? Mult Scler (2012) 1.54
Acute disseminated encephalomyelitis in childhood: epidemiologic, clinical and laboratory features. Pediatr Infect Dis J (2004) 1.52
Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis. J Neurol (2011) 1.51
Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: follow-up of 70 patients. Arch Neurol (2009) 1.51
Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis. Neurology (1996) 1.50
From diffusion tractography to quantitative white matter tract measures: a reproducibility study. Neuroimage (2003) 1.49
Acute disseminated encephalomyelitis cohort study: prognostic factors for relapse. Eur J Paediatr Neurol (2006) 1.49
Nephrogenic systemic fibrosis and gadolinium: a perfect storm. AJR Am J Roentgenol (2008) 1.45
Enhancing magnetic resonance imaging lesions and cerebral atrophy in patients with relapsing multiple sclerosis. Arch Neurol (2001) 1.45
Multiple sclerosis risk in radiologically uncovered asymptomatic possible inflammatory-demyelinating disease. Mult Scler (2009) 1.43
Evolution of T1 black holes in patients with multiple sclerosis imaged monthly for 4 years. Brain (2003) 1.43
A single, early magnetic resonance imaging study in the diagnosis of multiple sclerosis. Arch Neurol (2009) 1.41
Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement. Brain (2008) 1.38
Proton MR spectroscopy of tumefactive demyelinating lesions. AJNR Am J Neuroradiol (2002) 1.36
T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study. Arch Neurol (2002) 1.35
Radial diffusivity in remote optic neuritis discriminates visual outcomes. Neurology (2010) 1.35
Intraaxial brain masses: MR imaging-based diagnostic strategy--initial experience. Radiology (2007) 1.33
MRI prognostic factors for relapse after acute CNS inflammatory demyelination in childhood. Brain (2004) 1.31
MR imaging of relapsing multiple sclerosis patients using ultra-small-particle iron oxide and compared with gadolinium. AJNR Am J Neuroradiol (2006) 1.30
Multiple sclerosis: gadolinium enhancement in MR imaging. Radiology (1986) 1.29
MRI contrast uptake in new lesions in relapsing-remitting MS followed at weekly intervals. Neurology (2003) 1.29
Optic radiation changes after optic neuritis detected by tractography-based group mapping. Hum Brain Mapp (2005) 1.29
Quantitative assessment of MRI lesion load in multiple sclerosis. A comparison of conventional spin-echo with fast fluid-attenuated inversion recovery. Brain (1996) 1.27
Meningeal and cortical grey matter pathology in multiple sclerosis. BMC Neurol (2012) 1.27
Serial gadolinium-enhanced MRI of the brain and spinal cord in early relapsing-remitting multiple sclerosis. Neurology (1996) 1.25
Clinical-magnetic resonance imaging correlations in multiple sclerosis. J Neuroimaging (2005) 1.24
Cortical lesions and brain atrophy in MS. J Neurol Sci (2005) 1.24
Comparative immunopathogenesis of acute disseminated encephalomyelitis, neuromyelitis optica, and multiple sclerosis. Curr Opin Neurol (2007) 1.24
Gray and white matter volume changes in early RRMS: a 2-year longitudinal study. Neurology (2005) 1.20
Differentiation of multiple sclerosis from other inflammatory disorders and cerebrovascular disease: value of spinal MR imaging. Radiology (2002) 1.20
Memory impairment in multiple sclerosis: correlation with deep grey matter and mesial temporal atrophy. J Neurol Neurosurg Psychiatry (2008) 1.19
Multiple sclerosis: serial study of gadolinium-enhanced MR imaging. Radiology (1988) 1.18
Assessment of MRI criteria for a diagnosis of MS. Neurology (1993) 1.17
A serial in vivo 7T magnetic resonance phase imaging study of white matter lesions in multiple sclerosis. Mult Scler (2012) 1.16
MRI dynamics of brain and spinal cord in progressive multiple sclerosis. J Neurol Neurosurg Psychiatry (1996) 1.14
A longitudinal MRI study of histopathologically defined hypointense multiple sclerosis lesions. Ann Neurol (2001) 1.14
The thalamus and multiple sclerosis: modern views on pathologic, imaging, and clinical aspects. Neurology (2013) 1.48
The relevance of animal models in multiple sclerosis research. Pathophysiology (2011) 1.40
Induction of blood brain barrier tight junction protein alterations by CD8 T cells. PLoS One (2008) 1.38
CD8 T cell-initiated vascular endothelial growth factor expression promotes central nervous system vascular permeability under neuroinflammatory conditions. J Immunol (2009) 1.17
The role of CD8+ T-cells in lesion formation and axonal dysfunction in multiple sclerosis. Neurol Res (2006) 1.11
Antigen-specific CD8+ T cells mediate a peptide-induced fatal syndrome. J Immunol (2005) 1.09
The CD8 T cell in multiple sclerosis: suppressor cell or mediator of neuropathology? Int Rev Neurobiol (2007) 1.02
Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis. Mult Scler (2012) 1.01
Pathology of multiple sclerosis: where do we stand? Continuum (Minneap Minn) (2013) 0.96
MRI in rodent models of brain disorders. Neurotherapeutics (2011) 0.94
CD8 T cell-initiated blood-brain barrier disruption is independent of neutrophil support. J Immunol (2012) 0.94
A single dose of neuron-binding human monoclonal antibody improves spontaneous activity in a murine model of demyelination. PLoS One (2011) 0.94
A hematopoietic contribution to microhemorrhage formation during antiviral CD8 T cell-initiated blood-brain barrier disruption. J Neuroinflammation (2012) 0.94
Rapid formation of extended processes and engagement of Theiler's virus-infected neurons by CNS-infiltrating CD8 T cells. Am J Pathol (2010) 0.92
Potassium channel complex autoimmunity induced by inhaled brain tissue aerosol. Ann Neurol (2012) 0.90
Biogenesis and significance of central nervous system myelin. Semin Neurol (2012) 0.89
Positivity of cytomegalovirus antibodies predicts a better clinical and radiological outcome in multiple sclerosis patients. Neurol Res (2006) 0.88
Deletion of beta-2-microglobulin ameliorates spinal cord lesion load and promotes recovery of brainstem NAA levels in a murine model of multiple sclerosis. Brain Pathol (2012) 0.85
A potential role for CD8+ T-cells as regulators of CNS vascular permeability. Neurol Res (2006) 0.85
Advances in understanding gray matter pathology in multiple sclerosis: are we ready to redefine disease pathogenesis? BMC Neurol (2012) 0.84
A translatable molecular approach to determining CD8 T-cell epitopes in TMEV infection. Hum Immunol (2008) 0.83
Theiler's murine encephalomyelitis virus as an experimental model system to study the mechanism of blood-brain barrier disruption. J Neurovirol (2013) 0.81
Preserved vascular integrity and enhanced survival following neuropilin-1 inhibition in a mouse model of CD8 T cell-initiated CNS vascular permeability. J Neuroinflammation (2012) 0.80
MR microscopy of formalin fixed paraffin embedded histology specimens. Magn Reson Med (2014) 0.79
Pulsed intravenous methylprednisolone therapy in progressive multiple sclerosis: need for a controlled trial. Arch Neurol (2004) 0.78
Sensitivity vs specificity: progress and pitfalls in defining MRI criteria for pediatric MS. Neurology (2009) 0.78
Preclinical (1)H-MRS neurochemical profiling in neurological and psychiatric disorders. Bioanalysis (2012) 0.78
Iron deposition and inflammation in multiple sclerosis. Which one comes first? BMC Neurosci (2011) 0.78
Quantitative trait loci analysis reveals candidate genes implicated in regulating functional deficit and CNS vascular permeability in CD8 T cell-initiated blood-brain barrier disruption. BMC Genomics (2013) 0.76
MS cortical lesion or not? Double inversion recovery MRI reveals some answers and uncertainties. Neurology (2011) 0.75
In vivo detection of connectivity between cortical and white matter lesions in early MS. Mult Scler (2016) 0.75
Transcranial sonography of deep gray nuclei: a new outcome measure in multiple sclerosis? Neurology (2009) 0.75
Dietary factors and pediatric multiple sclerosis: A case-control study. Mult Scler (2017) 0.75